In vitro cytotoxicity assessment of ruxolitinib on oligodendrocyte precursor cell and neural stem/progenitor cell populations

JAK-STAT signaling cascade has emerged as an ideal target for the treatment of myeloproliferative diseases, autoimmune diseases, and neurological disorders. Ruxolitinib (Rux), is an orally bioavailable, potent and selective Janus-associated kinase (JAK) inhibitor, proven to be effective to target...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς: Lim, Cheng-Wei, Hamanaka, Gen, Liang, Anna C., Chan, Su Jing, Ling, King-Hwa, Lo, Eng H., Arai, Ken, Cheah, Pike See
Μορφή: Άρθρο
Γλώσσα:English
Έκδοση: Elsevier
Διαθέσιμο Online:http://psasir.upm.edu.my/id/eprint/113251/1/113251.pdf

Παρόμοια τεκμήρια